Exact Mass: 404.0899

Exact Mass Matches: 404.0899

Found 43 metabolites which its exact mass value is equals to given mass value 404.0899, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Citalopram hydrobromide

C20H22BrFN2O (404.0899)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators

VX-702

2-(2,4-Difluorophenyl)-6-[N-(2,6-difluorophenyl)(C-hydroxycarbonimidoyl)amino]pyridine-3-carboximidate

C19H12F4N4O2 (404.0896)

2-Hydroxy-6-methylbenzoic acid 4-(4-oxo-5,7-dihydroxy-4H-1-benzopyran-3-yl)phenyl ester

C23H16O7 (404.0896)

Saliniquinone A

C23H16O7 (404.0896)

pollenitin B

C16H20O12 (404.0955)

3-Methoxydiospyrin

C23H16O7 (404.0896)

DTXSID10873106

C23H16O7 (404.0896)

Asp-Tyr-OH

(S)-2-(3-(carboxymethoxy)-4-nitrobenzamido)-3-(4-hydroxyphenyl)propanoic acid

C18H16N2O9 (404.0856)

TC-S 7006

C21H14ClFN6 (404.0952)

2-naphthyl 4-phenylazophenyl phosphate*

C22H17N2O4P (404.0926)

2-[(4-chloro-2-nitrophenyl)azo]-N-(4-ethoxyphenyl)-3-oxobutyramide

C18H17ClN4O5 (404.0887)

1-Naphthyl 4-phenylazophenyl phosphate

C22H17N2O4P (404.0926)

3-(METHOXYCARBONYL)-5-(((4-NITROBENZYL)OXY)CARBONYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE-2-CARBOXYLIC ACID

C17H16N4O8 (404.0968)

9-ING-41

C22H13FN2O5 (404.0808)

Ethydiaminedhephen acetic sodium salt

C18H18N2Na2O6 (404.096)

Glycyladenylate

C12H17N6O8P (404.0845)

5-(p-Nitrophenyl)thioadenosine

C16H16N6O5S (404.0903)

Escitalopram hydrobromide

C20H22BrFN2O (404.0899)

(1R)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide

C20H22BrFN2O (404.0899)

5-(Aminomethyl)-6-(2,4-dichlorophenyl)-2-(3,5-dimethoxyphenyl)pyrimidin-4-amine

C19H18Cl2N4O2 (404.0807)

Glycyl-adenosine-5-phosphate

C12H17N6O8P (404.0845)

3-glycyl-AMP

C12H17N6O8P (404.0845)

A glycinyl ester obtained by formal condensation of the carboxy group of glycinne with the 3-hydroxy group of AMP.

2-(2-fluorophenoxy)-N-[4-(2-furanylmethylsulfamoyl)phenyl]acetamide

C19H17FN2O5S (404.0842)

N(2),N(2),N(7)-trimethylguanosine 5-phosphate(1-)

C13H19N5O8P- (404.0971)

N-[(4-nitrophenyl)methylene]-2-(10H-phenothiazin-10-yl)acetohydrazide

C21H16N4O3S (404.0943)

VX-702

C19H12F4N4O2 (404.0896)

Glycyl-AMP

C12H17N6O8P (404.0845)

Leramistat

C20H21ClN2O3S (404.0961)

Leramistat (HMC-C-01-A; MBS2320) is a mitochondrial complex 1 inhibitor, involving in cell metabolism immune metabolism regulation. Leramistat also inhibits ATP production in Thp1 human monocytes (IC50: 0.63 μM). Leramistat inhibits atopic dermatitis and other skin diseases autoimmune diseases, inflammatory diseases, cancer; and also inhibits osteoclast mediated disease[1][2][3].

1',5-dihydroxy-6'-methoxy-3',7-dimethyl-[2,2'-binaphthalene]-1,4,5',8'-tetrone

C23H16O7 (404.0896)

1',4-dihydroxy-6'-methoxy-2,3'-dimethyl-[1,2'-binaphthalene]-5,5',8,8'-tetrone

C23H16O7 (404.0896)

(2r,5'r,7s,7as)-5'-[(2-hydroxyphenyl)methyl]-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol

C19H20N2O4S2 (404.0864)